PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.7697
+0.0109 (1.44%)
At close: Jun 26, 2026, 4:00 PM EDT
0.7800
+0.0103 (1.34%)
After-hours: Jun 26, 2026, 7:49 PM EDT
PharmaCyte Biotech Market Cap
PharmaCyte Biotech has a market cap or net worth of $8.26 million as of June 26, 2026. Its market cap has increased by 11.67% in one year.
Market Cap
8.26M
Enterprise Value
-12.27M
1-Year Change
11.67%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since January 2, 2013, PharmaCyte Biotech's market cap has decreased from $17.00M to $8.26M, a decrease of -51.39%. That is a compound annual growth rate of -5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 8.30M | 13.70% |
| Dec 31, 2025 | 7.30M | -33.03% |
| Dec 31, 2024 | 10.90M | -41.40% |
| Dec 29, 2023 | 18.60M | -66.12% |
| Dec 30, 2022 | 54.90M | 5.98% |
| Dec 31, 2021 | 51.80M | 219.75% |
| Dec 31, 2020 | 16.20M | -72.16% |
| Dec 31, 2019 | 58.20M | 35.03% |
| Dec 31, 2018 | 43.10M | -23.17% |
| Dec 29, 2017 | 56.10M | -57.11% |
| Dec 30, 2016 | 130.80M | 266.39% |
| Dec 31, 2015 | 35.70M | -72.56% |
| Dec 31, 2014 | 130.10M | 108.16% |
| Dec 31, 2013 | 62.50M | 267.65% |
| Jan 2, 2013 | 17.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.38M |
| Aspire Biopharma Holdings | 8.35M |
| Addex Therapeutics | 8.18M |
| Ernexa Therapeutics | 8.17M |
| Immuron | 7.91M |
| MetaVia | 7.80M |
| HCW Biologics | 7.48M |
| Curanex Pharmaceuticals | 7.40M |